When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
FULC - Acceleron Pharma teams up with Fulcrum Therapeutics in pulmonary diseases
Fulcrum Therapeutics Inc.
Acceleron Pharma (XLRN-0.7%) inks a collaboration and license agreement with Fulcrum Therapeutics (FULC) aimed at identifying small molecules designed to modulate specific pathways associated with an undisclosed pulmonary disease indication.
More news on: Acceleron Pharma Inc., Fulcrum Therapeutics, Inc., Healthcare stocks news,